Potential role of the lncRNA "HOTAIR"/miRNA "206"/BDNF network in the alteration in expression of synaptic plasticity gene arc and BDNF level in sera of patients with heroin use disorder through the PI3K/AKT/mTOR pathway compared to the controls

Author:

Khalifa Fatma Nada,Hussein Riham F.,Mekawy Dina M.,Elwi Heba M.,Alsaeed Shimaa Ahmed,Elnawawy Yassmin,Shaheen Somaya H.

Abstract

Abstract Introduction Heroin use disorder (HUD) is a seriously increasing health issue, accounting for most deaths among drug abusers. Studying non-coding ribonucleic acid gene expression among drug abusers is a promising approach, as it may be used in diagnosis and therapeutics. Participants and methods A total of 49 male heroin-dependent patients and 49 male control participants were recruited from Kasr Al Ainy Psychiatry and Addiction outpatient clinics, Faculty of Medicine, Cairo University. Sera were gathered. qRT-PCR was utilized for the detection of gene expression of non-coding RNAs such as "HOX transcript antisense RNA" (HOTAIR), micro-RNA (miRNA-206), phosphatidylinositol 3-kinase (PI3K), protein kinase B (AKT), mechanistic target of rapamycin (mTOR), and Activity Regulated Cytoskeleton Associated Protein (Arc). Sera Brain-Derived Neurotrophic Factor (BDNF) levels were assessed using ELISA. Using a western blot made it possible to determine the protein expression of PI3K, AKT, and mTOR. Results The study demonstrated that gene expressions of HOTAIR, AKT, PI3K, and Arc were considerably lowered between cases and controls, while gene expressions of miR-206 and mTOR1 were significantly raised. PI3K and AKT protein expressions were downregulated, while mTOR expressions were upregulated. BDNF levels were significantly decreased in some cases. Conclusion The results of this study suggest that decreased HOTAIR in HUD relieves miR-206 inhibition, which thus increases and affects downstream PI3K/AKT/mTOR, ARC, and BDNF expression. This may be shared in addictive and relapsing behaviors. Graphical Abstract

Funder

Cairo University

Publisher

Springer Science and Business Media LLC

Reference56 articles.

1. Hamdi E, Sabry N, Sedrak A, Khowailed A, Rabie LN, Ramy H (2016) Addiction. J Addict Prev. https://doi.org/10.4103/1110-1105.195548

2. ATLAS of substance use disorders: Resources for the prevention and treatment of substance use disorders (SUD); country profile: Estonia. World Health Organization. 2010;

3. National Institute on Drug Abuse. Heroin Drug Facts. National Institute on Drug Abuse. 2022 [cited 2023 Jul 10]. Available from: https://nida.nih.gov/publications/drugfacts/heroin

4. Yassa HA, Badea ST (2019) Patterns of drug abuse in Upper Egypt: cause or result of violence? Egypt J Forensic Sci. https://doi.org/10.1186/s41935-019-0117-7

5. Butelman ER, Kreek MJ (2017) Medications for substance use disorders (SUD): emerging approaches. Expert Opin Emerg Drugs 22(4):301–315. https://doi.org/10.1080/14728214.2017.1395855

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3